Lexaria Bioscience Corp (LEXX)
3.13
+0.13
(+4.33%)
USD |
NASDAQ |
May 03, 16:00
3.11
-0.02
(-0.64%)
Pre-Market: 20:00
Lexaria Bioscience Total Assets (Quarterly): 6.352M for Feb. 29, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
February 29, 2024 | 6.352M |
November 30, 2023 | 3.627M |
August 31, 2023 | 3.084M |
May 31, 2023 | 5.240M |
February 28, 2023 | 4.855M |
November 30, 2022 | 6.214M |
August 31, 2022 | 7.834M |
May 31, 2022 | 9.138M |
February 28, 2022 | 11.41M |
November 30, 2021 | 11.75M |
August 31, 2021 | 13.27M |
May 31, 2021 | 10.55M |
February 28, 2021 | 12.17M |
November 30, 2020 | 2.174M |
August 31, 2020 | 2.828M |
May 31, 2020 | 3.320M |
February 29, 2020 | 1.986M |
November 30, 2019 | 2.746M |
August 31, 2019 | 2.675M |
May 31, 2019 | 3.457M |
February 28, 2019 | 4.274M |
November 30, 2018 | 3.544M |
August 31, 2018 | 2.432M |
May 31, 2018 | 2.709M |
February 28, 2018 | 2.841M |
Date | Value |
---|---|
November 30, 2017 | 2.497M |
August 31, 2017 | 2.860M |
May 31, 2017 | 3.144M |
February 28, 2017 | 0.8691M |
November 30, 2016 | 1.137M |
August 31, 2016 | 0.5666M |
May 31, 2016 | 0.3313M |
February 29, 2016 | 0.3894M |
November 30, 2015 | 0.4961M |
August 31, 2015 | 0.7117M |
May 31, 2015 | 1.199M |
February 28, 2015 | 1.210M |
November 30, 2014 | 2.251M |
July 31, 2014 | 4.566M |
April 30, 2014 | 4.838M |
January 31, 2014 | 3.560M |
October 31, 2013 | 3.573M |
July 31, 2013 | 3.683M |
April 30, 2013 | 3.799M |
January 31, 2013 | 3.923M |
October 31, 2012 | 4.192M |
July 31, 2012 | 4.224M |
April 30, 2012 | 4.131M |
January 31, 2012 | 4.228M |
October 31, 2011 | 4.339M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
1.986M
Minimum
Feb 2020
13.27M
Maximum
Aug 2021
6.234M
Average
5.047M
Median
Total Assets (Quarterly) Benchmarks
Aurinia Pharmaceuticals Inc | 548.06M |
Sunshine Biopharma Inc | 27.35M |
Acasti Pharma Inc | 76.18M |
Edesa Biotech Inc | 7.832M |
Xenon Pharmaceuticals Inc | 964.80M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 0.2042M |
Shareholders Equity (Quarterly) | 6.521M |
Current Ratio | 66.29 |